In COVID-19 clinical update #69, Daniel Griffin covers effectiveness of mRNA vaccines against the delta variant, depression among public health workers, correlates of protection against asymptomatic and symptomatic infection, BNT162b2 in ChAdOx-1-S primed individuals, prior infection rescues B and T cell responses to variants after vaccination, effect of vaccination on household transmission, germinal responses induced by mRNA vaccines, phase 3 results of Novavax vaccine, and long COVID as our next national health disaster.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Worry about human behavior, not variants (NY Times)
Moderna and Pfizer vaccines vs delta variant
Depression among public health workers (MMWR)
Correlates of protection (medRxiv)
mRNA vaccine in AZ recipients (Lancet)
Prior infection rescues B and T cell responses to variants (Science)
Effect of vaccination on household transmission (NEJM)
mRNA vaccines induce germinal responses (Nature)
Novavax vaccine phase 3 results (NEJM)
EUA for tocilizumab (FDA)
Long COVID, next national health disaster (NEJM)
Letters read on TWiV 775
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 775: COVID-19 clinical update #69 with Dr. Daniel Griffin